Cyanotech Corporation Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 7/6/2026)
| Balance Sheet | Total Assets | 22,125,000.00 | ROE | – |
| Balance Sheet | Total Equity | 7,660,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -142,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 92,000.00 | – | – |
| Cashflow | Operating Cash Flow | 234,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -0.18 | Div. Yield | – |
| Income | Net Income | -1,282,000.00 | P/E | – |
| Income | Shares Outstanding | 7,303,000.00 | P/B | – |
| Income | Total Revenue | 26,587,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Cyanotech Corporation (Cyanotech) produces natural products derived from microalgae. Cyanotech is engaged in the cultivation and production of microalgae into natural health and nutrition products. The Company cultivates two microalgal species from, which its two major product lines, spirulina products and natural astaxanthin products, are derived. The Company´s products include Hawaiian Spirulina Pacifica, which is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids, and Hawaiian BioAstin natural astaxanthin, which is a dietary antioxidant shown to support and maintain the body´s natural inflammatory response, to enhance skin, and to support eye and joint health. The Company´s wholly owned subsidiary is Nutrex Hawaii, Inc. (Nutrex).
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.cyanotech.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more